Grand Pharmaceutical Group Limited (HKG:0512)

Hong Kong · Delayed Price · Currency is HKD

7.67

+0.48 (6.68%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	11.64B	10.53B	9.56B	8.60B	6.35B
Pharmaceuticals Growth	10.59%	10.12%	11.22%	35.34%	-3.61%
Total	11.64B	10.53B	9.56B	8.60B	6.35B
Total Growth	10.59%	10.12%	11.22%	35.34%	-3.61%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
The People's Republic of China (PRC)	10.05B	8.72B	7.45B	7.42B	4.84B
The People's Republic of China (PRC) Growth	15.18%	17.01%	0.43%	53.28%	-10.83%
America	589.43M	687.45M	956.04M	430.10M	471.26M
America Growth	-14.26%	-28.09%	122.28%	-8.73%	-2.02%
Europe	478.29M	562.25M	566.53M	297.96M	356.33M
Europe Growth	-14.93%	-0.76%	90.14%	-16.38%	36.42%
Asia Other than The People's Republic of China (PRC)	474.96M	512.09M	480.81M	330.89M	530.09M
Asia Other than The People's Republic of China (PRC) Growth	-7.25%	6.51%	45.31%	-37.58%	67.95%
Others	55.98M	45.87M	105.11M	116.89M	152.91M
Others Growth	22.03%	-56.36%	-10.08%	-23.56%	49.14%
Total	11.64B	10.53B	9.56B	8.60B	6.35B
Total Growth	10.59%	10.12%	11.22%	35.34%	-3.61%

Source: S&P Global Market Intelligence.